Election 2026 – The nominations Germany

My professional role bridges several worlds: I oversee all regulatory and quality aspects of our cleanroom facilities and am primarily responsible for audits and compliance in sterile production. At the same time, I am deeply involved in therapeutic review, validating oncology treatment plans and working closely with prescribing physicians in an interprofessional setting. This combination of regulatory precision and clinical responsibility defines my approach to oncology pharmacy.

Unlike many pharmacits working in sterile manufacturing sites, i have the opportunity to also maintain a strong direct patient interface. I regularly counsel patients receiving our compounded sterile preparations as well as oral anticancer therapies. For me, oncology pharmacy does not end at production or verification – it culminates in meaningful patient interaction and pharmaceutical guidance.

I am an open-minded and highly motivated pharmacist and have been actively involved in the Deutsche Gesellschaft für Onkologische Pharmazie (DGOP) through working groups and the Summer Academy. There, I developed and delivered a lecture designed to bring oncology pharmacy practice in both community and hospital settings closer to pharmacy students.

As a candidate for ESOP delegate, I aim to contribute practical expertise, regulatory insight, and enthusiasm for advancing oncology pharmacy at a European level – connecting perspectives, strengthening collaboration, and shaping the future of our profession together. The unique situation public german pharmacies encounter when they contribute in oncology pharmacy and the information and insight which comes along with it is absolutely worth sharing.
Where Quality Meets Compassion.

Throughout my career, I have focused on optimizing the safe and effective use of oral cytotoxic agents, an area of growing clinical relevance and complexity. As chair of the ESOP Working Group “Oral Cancer Drugs” and member of the german working group on oral cytostatics, I have worked closely with colleagues across borders to develop practical guidance, share best practices, and address emerging challenges in cancer pharmacotherapy. These roles have enabled me to build a strong professional network and to actively connect international initiatives with national developments in Germany.
My long-standing and active involvement in the German society DGOP has given me insight into the needs and perspectives of our colleagues.

I am communicative, open to innovation, and committed to advancing our profession in a rapidly evolving healthcare landscape. I firmly believe that stronger collaboration between different countries will empower pharmacists to take an even more impactful role in oncology care.

It would be a great privilege to represent Germany at the ESOP Global level. I am driven by the shared goal of improving cancer care worldwide—ensuring that patients receive the highest quality counseling and support. Strengthening interprofessional collaboration with physicians and other healthcare professionals is central to this mission. Together, we can further elevate our profession and enhance outcomes for cancer patients across the world.